On this week’s Tech Nation, ever wondered what’s inside the lithium-ion batteries we use every day? Journalist Nicolas Niarchos joins Moira to talk about the minerals that power our modern life, and how the global race to control them is impacting the planet. Then, Dr Daniel Kraft tells us about the launch of ChatGPT Health. And, a fast-acting treatment for flare-ups of common inflammatory conditions could be around the corner.

On this week’s Tech Nation, Moira speaks with Marine biologist Dr Drew Harvell about her new book, "The Ocean’s Menagerie: How Earth’s Strangest Creatures Reshape the Rules of Life." Then, Sameer Sabir, CEO of Brixton Biosciences, explains their new injectable cold therapy in trials for knee pain. And, Erica Dhawan returns to explore the impact of tone in digital communication and why it often goes unnoticed.

On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.

On this week’s Tech Nation, Moira speaks with Dr. Shana Kelley, President of Bioengineering and Head of Biohub Chicago,  about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr. Harry Selker and Dr. Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.

On this week’s Tech Nation, with the 44th Annual J.P. Morgan Healthcare Conference around the corner, we delve into three ongoing efforts in biotech. Moira speaks with Cyriac Roeding and Dr David Suhy, Co-Founders of Earli, about their innovative approach to treating solid tumour cancer. Then, Ketan Mehta of Tris Pharma discusses the potential of a euphoria-suppressing opioid. And Neil Klompas of Augurex Life Sciences talks about a new diagnostic for patients with chronic back pain that pinpoints an easily-missed form of arthritis.

BTN TITLE: Can Cancer Cells be Turned Against Themselves?

This week on BioTech Nation, Moira speaks with Cyriac Roeding and Dr David Suhy, Co-Founders of Earli, about an innovative new approach to solid tumour cancer. They discuss their effort to turn the cancer cells inside solid tumours into factories that produce their own cancer-fighting therapies.

On this week’s Tech Nation, Moira speaks with author and environmental thought leader Paul Hawken to discuss his latest book, "Carbon: The Book of Life", about the invisible forces shaping our planet and the actions that can transform our future. He challenges us to rethink climate, commerce, and our own beliefs.

On this week’s Tech Nation, Moira speaks with Dr Christopher Summerfield, Professor of Cognitive Science at the University of Oxford and author of "These Strange New Minds … How AI Learned to Talk and What It Means," on how AI is changing our world. Then, Professor Niels Riedemann, Co-Founder & CEO of InflaRx, explains how the body’s immune system sometimes turns against itself and what can be done to prevent it.

On this week’s Tech Nation, Moira speaks with Dr. Alexandra Shaker, Clinical Psychologist and author of "The Narrowing … A Journey Through Anxiety and the Body," exploring what anxiety really is and how our gut instinct and genetics play a role in our response. Then, Dr. Thomas Chen, Director of Neuro-oncology at USC and Founder of NeOnc Technologies, discusses an innovative method to deliver drugs directly to the brain to treat glioblastoma and other brain cancers.

On this week’s Tech Nation, Emeritus Professor of Economics, Gary Smith, addresses the question of an AI bubble: is there one? And what will be the economic impact if it bursts? Then, CEO Martin Burns explains how Bruin Biometrics aims to prevent a potentially fatal condition affecting more than 2.5 million Americans each year.

BTN Title: Preventing Pressure Injuries: Detecting the Invisible Signs

Bruin Biometrics CEO, Martin Burns, talks about a new diagnostic tool being used to detect and prevent potentially fatal bedsores in their earliest stages.

On this week’s Tech Nation, Moira speaks with Dr. Ashley Shew, Professor of Science, Technology, and Society at Virginia Tech and author of, "Against Technoableism... Rethinking Who Needs Improvement", about how technology influences our perception of disability and whether it truly helps those it aims to support. Then, Dr. Ari Azhir, CEO of Neuvivo, discusses how her company revived a once-failed ALS drug by re-examining clinical trial data, uncovering its potential to treat Huntington’s, Alzheimer’s, and Vascular Dementia.